Validation of a clinical prediction score to target viral load testing in adults with suspected first-line treatment failure in resource-constrained settings

Journal of Acquired Immune Deficiency Syndromes

Volumn 62, Issue 5, 2013, Pages 509-516

  Phan, Vichet ^a   Thai, Sopheak ^a   Koole, Olivier ^b   Menten, Joris ^b   Meheus, Filip ^b   Van Griensven, Johan ^a,b   Lynen, Lutgarde ^b  

^a Sihanouk Hospital Center of HOPE   (Cambodia)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

Algorithm; Antiretroviral; Failure; Hiv; Prediction score; Validation; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; LAMIVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS TENOFOVIR DISOPROXIL; LAMIVUDINE PLUS NEVIRAPINE PLUS ZIDOVUDINE; NEVIRAPINE; STAVUDINE; TENOFOVIR DISOPROXIL; ZIDOVUDINE;

ADULT; ARTICLE; CAMBODIA; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CLINICAL ASSESSMENT; CLINICAL PREDICTOR SCORE; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG TREATMENT FAILURE; FEMALE; HEALTH PROGRAM; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; VIRUS LOAD;

ADULT; ALGORITHMS; ANTI-HIV AGENTS; AREA UNDER CURVE; CAMBODIA; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LONGITUDINAL STUDIES; MALE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, VIRAL; ROC CURVE; VIRAL LOAD;

EID: 84876408892     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318285d28c     Document Type: Article

References (31)

1. World Health Organization. Global HIV/AIDS Response: Epidemic Update and Health Sector Progress Towards Universal Access: Progress Report, November 2011. Geneva, Switzerland: World Health Organization; 2011.
2. Lynen L, Van Griensven J, Elliott J. Monitoring for treatment failure in patients on first-line antiretroviral treatment in resource-constrained settings. Curr Opin HIV AIDS. 2010;5:1-5.
3. Kahn JG, Marseille E, Moore D, et al. CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study. BMJ. 2011;343:d6884.
4. Laurent C, Kouanfack C, Laborde-Balen G, et al. Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial. Lancet Infect Dis. 2011;11:825-833.
5. Mermin J, Ekwaru JP, Were W, et al. Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial. BMJ. 2011;343:d6792.
6. World Health Organization. Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach, 2006 Revision. Geneva, Switzerland: World Health Organization; 2006.
7. Lynen L, An S, Koole O, et al. An algorithm to optimize viral load testing in HIV-positive patients with suspected first-line antiretroviral therapy failure in Cambodia. J Acquir Immune Defic Syndr. 2009;52:40-48.
8. Rawizza HE, Chaplin B, Meloni ST, et al. Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings. Clin Infect Dis. 2011;53:1283-1290.
9. World Health Organization. Antiretroviral Therapy for HIV Infection in Adults and Adolescents, Recommendations for a Public Health Approach, 2010 Revision. Geneva, Switzerland: World Health Organization, 2010.
10. Abouyannis M, Menten J, Kiragga A, et al. Development and validation of systems for rational use of viral load testing in adults receiving firstline ART in sub-Saharan Africa. AIDS. 2011;25:1627-1635.
11. Thai S, Koole O, Un P, et al. Five-year experience with scaling-up access to antiretroviral treatment in an HIV care programme in Cambodia. Trop Med Int Health. 2009;14:1048-1058.
12. Van Griensven J, Thai S. Predictors of immune recovery and the association with late mortality while on antiretroviral treatment in Cambodia. Trans R Soc Trop Med Hyg. 2011;105:694-703.
13. Ferradini L, Laureillard D, Prak N, et al. Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia. AIDS. 2007;21:2293-2301.
14. Pujades-Rodriguez M, Schramm B, Som L, et al. Immunovirological outcomes and resistance patterns at 4 years of antiretroviral therapy use in HIVinfected patients in Cambodia. Trop Med Int Health. 2011;16:205-213.
15. Barth RE, van der Loeff MF, Schuurman R, et al. Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review. Lancet Infect Dis. 2010;10:155-166.
16. Vorkas CK, Tweya H, Mzinganjira D, et al. Practices to improve identification of adult antiretroviral therapy failure at the Lighthouse Trust clinic in Lilongwe, Malawi. Trop Med Int Health. 2012;17:169-176.
17. McGinn TG, Guyatt GH, Wyer PC, et al. Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence- Based Medicine Working Group. JAMA. 2000;284:79-84.
18. Colebunders R, Moses KR, Laurence J, et al. A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries. Lancet Infect Dis. 2006;6:53-59.
19. Meya D, Spacek LA, Tibenderana H, et al. Development and evaluation of a clinical algorithm to monitor patients on antiretrovirals in resourcelimited settings using adherence, clinical and CD4 cell count criteria. J Int AIDS Soc. 2009;12:3.
20. Egger M, Keiser O, Zhou J, et al. CD4 cell response and virologic failure: a risk chart. Abstract 634. Presented at the 19th Conference on Retroviruses and Opportunistic Infections; March 5-8, 2012; Seatlle, WA.
21. Labhardt ND, Lejone T, Setoko M, et al. A clinical prediction score in addition to WHO criteria for antiretroviral treatment failure in resourcelimited settings-experience from Lesotho. PLoS One. 2012;7:e47937.
22. Saag M, Westfall A, Luhanga D, et al. A cluster randomized trial of routine vs discretionary viral load monitoring among adults starting ART: Zambia. Abstract 87. Presented at the 19th conference on retroviruses and opportunistic infections; March 5-8, 2012; Seatlle, WA.
23. Johnston V, Fielding K, Charalambous S, et al. Outcomes following virological failure and predictors of switching to second-line ART: a multi- site treatment program in South Africa. Abstract 644. Presented at 19th Conference on Retroviruses and Opportunistic Infections; March 5-8, 2012; Seattle, WA. 2012.
24. Hosseinipour MC, van Oosterhout JJ, Weigel R, et al. The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing firstline antiretroviral therapy. AIDS. 2009;23:1127-1134.
25. Phillips AN, Pillay D, Garnett G, et al. Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settings. AIDS. 2011;25:843-850.
26. Castelnuovo B, Byakwaga H, Menten J, et al. Can response of a pruritic papular eruption to antiretroviral therapy be used as a clinical parameter to monitor virological outcome? AIDS. 2008;22:269-273.
27. Hamers RL, Wallis CL, Kityo C, et al. HIV-1 drug resistance in antiretroviral- naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study. Lancet Infect Dis. 2011;11:750-759.
28. Lynen L, Fransen K, Van Griensven J, et al. Pretreatment HIV-1 drug resistance testing in sub-Saharan Africa. Lancet Infect Dis. 2012;12:911.
29. Coetzee D, Boulle A, Hildebrand K, et al. Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa. AIDS. 2004;18(suppl 3):S27-S31.
30. Castelnuovo B, Sempa J, Agnes KN, et al. Evaluation of WHO criteria for viral failure in patients on antiretroviral treatment in resource-limited settings. AIDS Res Treat. 2011;2011:736938.
31. Sopheab H, Saphonn V, Chhea C, et al. Distribution of HIV in Cambodia: findings from the first national population survey. AIDS. 2009;23: 1389-1395.